RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Arecor Therapeutics Stock

Arecor Therapeutics Debt 2024

Arecor Therapeutics Debt

-4.76 GBP

Ticker

AREC.L

ISIN

GB00BMWLM973

WKN

A3CRY2

In 2024, Arecor Therapeutics's total debt was -4.76 GBP, a 6.21% change from the -4.48 GBP total debt recorded in the previous year.

Arecor Therapeutics Aktienanalyse

What does Arecor Therapeutics do?

Arecor Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Arecor Therapeutics's Debt Structure

Arecor Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Arecor Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Arecor Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Arecor Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Arecor Therapeutics stock

What is the debt of Arecor Therapeutics this year?

Arecor Therapeutics has a debt level of -4.76 GBP this year.

What was the debt of Arecor Therapeutics compared to the previous year?

The debt of Arecor Therapeutics has increased by 6.21% compared to the previous year increased.

What are the consequences of high debt for investors in Arecor Therapeutics?

High debt can pose a risk for investors of Arecor Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Arecor Therapeutics?

Low debt means that Arecor Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Arecor Therapeutics affect the company?

An increase in debt of Arecor Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Arecor Therapeutics affect the company?

A reduction in debt of Arecor Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Arecor Therapeutics?

Some factors that can influence the debt of Arecor Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Arecor Therapeutics so important for investors?

The debts of Arecor Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Arecor Therapeutics take to change the debt?

To change the debt, Arecor Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Arecor Therapeutics pay?

Over the past 12 months, Arecor Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arecor Therapeutics is expected to pay a dividend of 0 GBP.

What is the dividend yield of Arecor Therapeutics?

The current dividend yield of Arecor Therapeutics is .

When does Arecor Therapeutics pay dividends?

Arecor Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arecor Therapeutics?

Arecor Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Arecor Therapeutics?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arecor Therapeutics located?

Arecor Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Arecor Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arecor Therapeutics from 10/2/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Arecor Therapeutics pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Arecor Therapeutics in the year 2023?

In the year 2023, Arecor Therapeutics distributed 0 GBP as dividends.

In which currency does Arecor Therapeutics pay out the dividend?

The dividends of Arecor Therapeutics are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Arecor Therapeutics

Our stock analysis for Arecor Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Arecor Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.